Debut Plus

₹520.05

▲ +7.33 +1.43%

As of 23 Oct 2026 · delayed

NSE Listed

Lincoln Pharmaceuticals Ltd. (LINCOLN)

Volume: 35,181Avg Vol 1W: 37,555.2Avg Vol 1M: 29,447.0552W Range:₹440₹770
NSE BSE www.lincolnpharma.com AI Report
Key Ratios
Checked 7h ago
Market Cap₹1,027 Cr
Current Price₹520.05
Previous Close₹512.72
High / Low (52w)₹770 / ₹440
Volume35,181
Avg Vol (1W)37,555.2
Avg Vol (1M)29,447.05
Stock P/E13.42
Book Value₹335.34
Dividend Yield—
ROE13%
ROA—
Revenue (TTM)₹646 Cr
Revenue Growth—
Profit Margin—
Total Debt₹0 Cr
Shares Outstanding—
Face Value₹10
EPS (TTM)₹41.11
P/B1.64
Debt / Equity0
50 DMA₹591.76
200 DMA₹597.66
Day change+1.43%
Price Chart
₹520.05▼ 1.62% · 1Y
₹758₹44436.7L
2025-10-27
2026-10-23

20-day avg volume: 29K shares

Pros
  • Company is almost debt-free.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹161 Cr₹147 Cr₹168 Cr₹154 Cr₹163 Cr₹166 Cr₹187 Cr₹177 Cr
EBITDA₹35 Cr₹29 Cr₹17 Cr₹36 Cr₹29 Cr₹35 Cr₹17 Cr₹48 Cr
Net Profit₹26 Cr₹21 Cr₹12 Cr₹28 Cr₹20 Cr₹29 Cr₹12 Cr₹36 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹646 Cr₹168 Cr₹154 Cr₹163 Cr₹166 Cr₹187 Cr₹704 Cr₹177 Cr
EBITDA₹111 Cr₹17 Cr₹36 Cr₹29 Cr₹35 Cr₹17 Cr₹117 Cr₹48 Cr
Net Profit₹82 Cr₹12 Cr₹28 Cr₹20 Cr₹29 Cr₹12 Cr₹88 Cr₹36 Cr
EPS41.11—————43.88—
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹366 Cr₹389 Cr₹452 Cr₹534 Cr₹587 Cr₹700 Cr₹797 Cr₹890 Cr
Total Liabilities₹96 Cr₹76 Cr₹86 Cr₹101 Cr₹85 Cr₹107 Cr₹125 Cr₹133 Cr
Equity₹270 Cr₹313 Cr₹366 Cr₹433 Cr₹502 Cr₹593 Cr₹672 Cr₹758 Cr
Total Debt————————
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹70 Cr₹90 Cr₹89 Cr₹100 Cr₹69 Cr₹89 Cr₹119 Cr₹131 Cr
Investing₹-18 Cr₹-31 Cr₹-64 Cr₹-78 Cr₹-37 Cr₹-57 Cr₹-79 Cr₹-98 Cr
Financing₹-36 Cr₹-38 Cr₹-6 Cr₹-3 Cr₹-5 Cr₹-5 Cr₹-6 Cr₹0 Cr
Free Cash Flow₹70 Cr₹90 Cr₹89 Cr₹100 Cr₹69 Cr₹89 Cr₹119 Cr₹132 Cr
Shareholding
Promoter 49.78% Institutions 4.55% Public 45.67%
Efficiency & Working Capital
ROCE15.2%
Interest Coverage115.5
Dividend Payout—
Debtor Days88 d
Inventory Days44 d
Payable Days46 d
Cash Conversion Cycle85 d
Working Capital Days131 d
Shareholding Details

As of 2026-09-30

Promoter49.8%
FII4.6%
DII0%
Institutions4.6%
Public45.7%
Promoter Pledge0%
No. of Shareholders29,272
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodDec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Promoters49.8%49.5%49.8%49.8%49.8%49.8%49.8%49.8%49.8%49.8%49.8%49.8%
FIIs3.2%3.9%3.9%5.2%5.2%5%5.1%4.7%4.7%5.2%4.6%4.6%
DIIs0%0.1%0%0%0%0%0%0%0%1.1%0.3%0%
Public47%46.5%46.2%45%45.1%45.2%45.1%45.5%45.5%43.9%45.4%45.7%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders29,31631,37529,96731,33031,84831,86731,78432,37031,02628,30329,39629,272
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Munjal Mahendrabhai PatelShareholding of Promoter and Promoter Group13.4%26,78,800
Ashish Rajanikant PatelShareholding of Promoter and Promoter Group10.6%21,22,902
Rajanikant Gulabdas PatelShareholding of Promoter and Promoter Group3.8%7,56,801
Mahendrabhai Gulabdas PatelShareholding of Promoter and Promoter Group3.4%6,75,000
Sunmed Corporation LlpShareholding of Promoter and Promoter Group2.5%5,00,000
Kailashben Mahendrabhai PatelShareholding of Promoter and Promoter Group2.4%4,80,000
Kishor M. ShahPublic Shareholding2.4%4,78,400
Downtown Travels LlpShareholding of Promoter and Promoter Group2.4%4,75,000
Hasmukhbhai Ishwarbhai PatelShareholding of Promoter and Promoter Group1.9%3,73,600
Anand Arvinbhai PatelShareholding of Promoter and Promoter Group1.7%3,32,000
Rimo Capital Fund LpPublic Shareholding1.4%2,70,450
Dheeraj Kumar LohiaPublic Shareholding1.2%2,48,816
Shivani Ashish PatelShareholding of Promoter and Promoter Group1%2,06,475
Mansi Munjal PatelShareholding of Promoter and Promoter Group1%2,00,000
Hansaben Arvindbhai PatelShareholding of Promoter and Promoter Group0.9%1,77,200
Patel Nishitkumar MaheshbhaiShareholding of Promoter and Promoter Group0.8%1,53,400
Dharmisthaben Bhagirath PatelShareholding of Promoter and Promoter Group0.6%1,24,459
Arvindbhai Gulabdas PatelShareholding of Promoter and Promoter Group0.6%1,11,000
Downtown Finance Pvt. Ltd.Shareholding of Promoter and Promoter Group0.5%1,06,000
Renukaben Maheshbhai PatelShareholding of Promoter and Promoter Group0.5%98,047
Jigar Hasmukhbhai PatelShareholding of Promoter and Promoter Group0.4%86,200
Patel Aniruddh HShareholding of Promoter and Promoter Group0.4%86,200
Mihir Viththalbhai PatelShareholding of Promoter and Promoter Group0.4%82,669
Dharmistaben Hasmukhbhai PatelShareholding of Promoter and Promoter Group0.3%65,003
Nidhi Mahendrabhai PatelShareholding of Promoter and Promoter Group0.3%54,000
Board of Directors
NameDesignationYear
Kishorbhai M ShahChairman & Non Executive Dir.2025
Mahendra G PatelED / MD / Promoter2025
Hasmukhbhai I PatelWTD & Executive Director2025
Ashish Rajanikant PatelWTD & Executive Director2025
Munjal Mahendrabhai PatelWTD & Executive Director2025
Rajnikant G PatelNon-Exec & Non-Independent Dir2025
Saurin Jagdish Bhai ParikhIndependent Non Exe. Director2025
Nareshkumar Pirabhai SutharIndependent Non Exe. Director2025
Seema MehtaIndependent Non Exe. Director2025
Trusha ShahCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Pharmaceutical₹159 Cr75.9%
Chemicals₹50 Cr24.1%
Segments — Geography
RegionRevenueShare
Domestic₹236 Cr37.9%
Export₹387 Cr62.1%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10322020
Corporate Actions
TypeDateValueRemark
forthcoming2026-09-11Dividend—
dividend2026-09-11₹1.8 (18%)Final
forthcoming2026-08-13Board Meetings—
dividend2025-09-12₹1.8 (18%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202500041824
202500001717
2025000417
Insider / Designated-Person Trades

30 recent disclosure(s)

Munjal Mahendrabhai PatelAcquisition · 13,500
Munjal Mahendrabhai PatelAcquisition · 20,000
Munjal Mahendrabhai PatelAcquisition · 15,000
Patel Nishitkumar MaheshbhaiDisposal · 1,000
Patel Nishitkumar MaheshbhaiDisposal · 1,000
Renukaben Maheshbhai PatelDisposal · 1,500
Substantial Acquisitions (SAST)

25 disclosure(s)

Market04/06/2024 · 13,500
Market31/05/2024 - 03/06/2024 · 35,000
Market27/02/2024 · 1,000
Market26/02/2024 · 1,500
Market26/02/2024 · 1,000
Market23/02/2024 · 62,500
Company Information
Incorporated1995
ChairmanKishorbhai M Shah
AuditorSamir M Shah & Associates
Investor Email[email protected]; [email protected]
🌐 www.lincolnpharma.com ↗

📍 Lincoln House B/H Satyam Compe, Science City Road Sola, Ahmedabad, Gujarat, 380060

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Libas Consumer Products Ltd.Liberty Shoes Ltd.LIC Housing Finance Ltd.Life Insurance Corporation of IndiaLikhitha Infrastructure Ltd.Linc LimitedLinde India LimitedLiotech Industries LimitedL K P Securities Ltd.Lloyds Luxuries LimitedLloyds Engineering Works Ltd.Lloyds Enterprises Ltd.All “L” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search